Category: Latest News
-

H.B. Fuller Shares Flat After Board Rejects Ancora’s $1.2 Billion Adhesives Bid
H.B. Fuller Co. (NYSE:FUL) shares were unchanged in Monday’s pre-market trading after the company’s board rejected an unsolicited offer from Ancora Holdings Group worth up to $1.2 billion for its Building Adhesive Solutions business, according to Bloomberg, citing people familiar with the matter. The board determined that Ancora’s proposal materially undervalued the division and failed…
-

RUM Group Shares Surge 10% After Signing $13.7 Billion GPU Services Agreement
RUM Group Inc. (RUM) shares jumped 10% on Monday after the company disclosed a six-year GPU services agreement worth approximately $13.7 billion with an unaffiliated U.S.-based cloud customer. The agreement, dated August 23, 2026, covers GPU services that will be delivered from RUM Group’s Maysville, Georgia facility, which is currently under development. The total order…
-

BriaCell Shares Turn Volatile After Melanoma Vaccine Development Milestone
BriaCell Therapeutics (NASDAQ:BCTX) shares experienced a volatile session on Monday after the biotechnology company announced that its Bria-MEL+ melanoma vaccine candidate had reached an important genetic engineering milestone. The stock initially jumped 25% following the announcement before surrendering those gains later in the session, highlighting the market’s shifting reaction to the development-stage programme. BriaCell said…
-

NAPCO Security Shares Surge 20% After Earnings Beat and Record Revenue
NAPCO Security Technologies, Inc. (NASDAQ:NSSC) shares soared 20.50% in pre-market trading on Monday after the security technology company delivered fourth-quarter results that exceeded Wall Street expectations, supported by record revenue and continued growth in its recurring services business. Adjusted earnings came in at $0.50 per share, beating the analyst consensus estimate of $0.39 by $0.11.…
-

REGENXBIO Shares Plunge After FDA Places Clinical Hold on RGX-121
REGENXBIO Inc. (NASDAQ:RGNX) shares tumbled 35% after the U.S. Food and Drug Administration placed a clinical hold on RGX-121, the company’s investigational gene therapy for Mucopolysaccharidosis type II (MPS II), also known as Hunter Syndrome. The regulatory action followed the identification of asymptomatic findings in spine MRI scans from five participants in the CAMPSIITE study.…
-

Gogoro Shares Slide 15% Despite Smaller Loss and Stronger Margins
Gogoro Inc (NASDAQ:GGR) shares fell sharply in pre-market trading despite the battery-swapping specialist reporting improved second-quarter financial results, including a substantially narrower net loss and its strongest gross margin in more than five years. The stock dropped 15.42% following the results, even as quarterly revenue increased and several key profitability and cash-flow measures strengthened. Gogoro…
-

USA Rare Earth Completes $1.55 Billion SPV Funding for Serra Verde Offtake
USA Rare Earth, Inc. (NASDAQ:USAR) has completed the $1.55 billion capitalisation of a special purpose vehicle established to acquire 100% of Phase 1 rare earth production from Serra Verde Group, marking a key step towards completing its planned acquisition of the business. The financing includes a $750 million commitment from the U.S. Department of War,…
-

XPeng Shares Fall After Q2 Miss as Robotics Unit Raises More Than $900 Million
XPeng (NYSE:XPEV) shares moved lower in U.S. pre-market trading on Monday after the Chinese electric vehicle manufacturer reported second-quarter revenue and earnings below analyst expectations. The company also announced a major financing round for its robotics division, valuing the business at more than $6.3 billion. XPeng reported a second-quarter loss of RMB1.29 per share, considerably…
-

PDD Holdings Shares Rise After Second-Quarter Earnings Beat
PDD Holdings Inc. (NASDAQ:PDD) shares gained 1% in pre-market trading after the e-commerce group reported second-quarter earnings that topped analyst expectations, although revenue came in slightly below forecasts. The company posted adjusted earnings per ADS of RMB19.33 ($2.85), ahead of the RMB18.35 consensus estimate. Revenue increased 8% year on year to RMB112.4 billion ($16.6 billion),…
-

Exxon Expands Automated Drilling in Permian to Boost Oil Production
ExxonMobil (NYSE:XOM) is stepping up its use of automated drilling technology in the Permian Basin as the U.S. energy major seeks to improve safety, accelerate well development and support a substantial increase in oil production. At automated rigs in West Texas, robotic equipment is increasingly taking over tasks traditionally performed by workers on the drilling…